Spara
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Läs i Adobe DRM-kompatibel e-boksläsareDen här e-boken är kopieringsskyddad med Adobe DRM vilket påverkar var du kan läsa den. Läs mer
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
- Författare
- Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine
- Redaktör
- John R. Ball, Christine M. Micheel
- ISBN
- 9780309151306
- Språk
- Engelska
- Utgivningsdatum
- 2010-06-25
- Förlag
- National Academies Press
- Tillgängliga elektroniska format
- PDF - Adobe DRM
- Läs e-boken här
- E-boksläsare i mobil/surfplatta
- Läsplatta
- Dator
